Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Hold
1,910
0.1% 77
2026
Q1
$231K Hold
1,910
0.11% 73
2025
Q4
$203K Hold
1,910
0.11% 82
2025
Q3
$162K Sell
1,910
-8,399
-81% -$692K 0.09% 84
2025
Q2
$824K Sell
10,309
-3,856
-27% -$307K 0.3% 64
2025
Q1
$1.28M Buy
14,165
+5
+0% +$467 0.55% 28
2024
Q4
$1.41M Buy
+14,160
New +$1.46M 0.61% 31

Other funds holding MRK

1248 Management's MRK Position: Q2 2026 in Review

1248 Management held its Merck (MRK) position steady in Q2 2026 at 1,910 shares worth $247K. The position accounts for 0.1% of the portfolio, ranked #77.

1248 Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.41M in Q4 2024. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • 1248 Management held 1,910 shares of Merck worth $247K as of Q2 2026.
  • 1248 Management left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.1% of 1248 Management's portfolio in Q2 2026, its #77 holding.
  • 1248 Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1248 Management's Merck position peaked at $1.41M in Q4 2024.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on 1248 Management's 13F filing for Q2 2026, filed 13 Aug 2026.